A NEW INDICATION FOR SYMBICORT AS A COMBO RELIEVER + MAINTENANCE TREATMENT FOR ASTHMA AND COPD WAS THE CATALYST TO TRANSFORM AN EXISTING PRODUCT INTO A GROUND-BREAKING, GLOBAL MARKET LEADER.